VioQuest Pharmaceuticals Report issue

For profit Phase 1 Phase 2
Founded: Basking Ridge NJ United States (2000)
Status: Defunct (2016)

Organization Overview

First Clinical Trial
2006
NCT00363454
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

interferon alpha-2b (Intron-A) (2 trials)

sodium stibogluconate (Pentostam) (2 trials)

Drugs in Phase 1 Trials (1)

triciribine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Leukemia (Phase 1)

Neoplasm Metastasis (Phase 1)

Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 4